Investing

Top Analyst Upgrades and Downgrades: Enbridge, Micron, Sun Life, Starbucks, Stratasys, Wynn and Many More

AbbVie Inc. (NYSE: ABBV) was maintained as Buy at Goldman Sachs, but the company was removed from the Conviction Buy List and the price target was cut to $68 from $80.

AveXis Inc. (NASDAQ: AVXS) was started as Buy with a $27 price target (versus a $19.67 close) at Jefferies.

Bancolombia S.A. (NYSE: CIB) was raised to Outperform from Neutral at Credit Suisse.

Cardinal Health Inc. (NYSE: CAH) already was rated as Buy but was added to the prized Conviction Buy List at Goldman Sachs.

Carmike Cinemas Inc. (NASDAQ: CKEC) was downgraded to Hold from Buy at Topeka Capital Markets. Wedbush Securities also downgraded it to Neutral from Outperform.

Helen of Troy Ltd. (NASDAQ: HELE) was started with a Buy rating and $114 price target (versus a $97.98 close) at Jefferies.

InterContinental Hotels Group PLC (NYSE: IHG) was downgraded to Sell from Neutral at Citigroup.

Kimco Realty Corp. (NYSE: KIM) was downgraded to Hold from Buy at Argus.


Mesoblast Ltd. (NASDAQ: MESO) was downgraded to Neutral from Overweight at JPMorgan.

Proteostasis Therapeutics Inc. (NASDAQ: PTI) was started as Outperform with a $20 price target (versus a $5.56 close) at RBC Capital Markets. It was also started as Buy with a $15 price target at H.C. Wainwright.

Randgold Resources Ltd. (NASDAQ: GOLD) was downgraded to Equal Weight from Overweight at Morgan Stanley.

Regions Financial Corp. (NYSE: RF) was reiterated as Buy with an $11 price target (versus an $8.39 close) at Jefferies.

In case you missed Friday’s top analyst calls, they included Apple, Broadcom, DSW, SBA Communications, Tyson Foods and a dozen or so other companies.